157 related articles for article (PubMed ID: 34056767)
1. GAB1 overexpression identifies hedgehog-activated anterior skull base meningiomas.
Boetto J; Lerond J; Peyre M; Tran S; Marijon P; Kalamarides M; Bielle F
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):748-755. PubMed ID: 34056767
[TBL] [Abstract][Full Text] [Related]
2. GAB1 as a Marker of Recurrence in Anterior Skull Base Meningioma.
Boetto J; Bielle F; Tran S; Marijon P; Peyre M; Rigau V; Kalamarides M
Neurosurgery; 2023 Feb; 92(2):391-397. PubMed ID: 36637273
[TBL] [Abstract][Full Text] [Related]
3. Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.
Boetto J; Apra C; Bielle F; Peyre M; Kalamarides M
Oncogene; 2018 Sep; 37(36):4955-4963. PubMed ID: 29789719
[TBL] [Abstract][Full Text] [Related]
4. Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.
Strickland MR; Gill CM; Nayyar N; D'Andrea MR; Thiede C; Juratli TA; Schackert G; Borger DR; Santagata S; Frosch MP; Cahill DP; Brastianos PK; Barker FG
J Neurosurg; 2017 Aug; 127(2):438-444. PubMed ID: 27885953
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of the hedgehog signaling pathway in human meningiomas.
Laurendeau I; Ferrer M; Garrido D; D'Haene N; Ciavarelli P; Basso A; Vidaud M; Bieche I; Salmon I; Szijan I
Mol Med; 2010; 16(7-8):262-70. PubMed ID: 20386868
[TBL] [Abstract][Full Text] [Related]
6. Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells.
Scheidt T; Alka O; Gonczarowska-Jorge H; Gruber W; Rathje F; Dell'Aica M; Rurik M; Kohlbacher O; Zahedi RP; Aberger F; Huber CG
Cell Commun Signal; 2020 Jun; 18(1):99. PubMed ID: 32576205
[TBL] [Abstract][Full Text] [Related]
7. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
[TBL] [Abstract][Full Text] [Related]
8. Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW; Erson-Omay Z; Li C; Najem H; Coșkun S; Tyrtova E; Montejo JD; Miyagishima DF; Barak T; Nishimura S; Harmancı AS; Clark VE; Duran D; Huttner A; Avşar T; Bayri Y; Schramm J; Boetto J; Peyre M; Riche M; Goldbrunner R; Amankulor N; Louvi A; Bilgüvar K; Pamir MN; Özduman K; Kilic T; Knight JR; Simon M; Horbinski C; Kalamarides M; Timmer M; Heimberger AB; Mishra-Gorur K; Moliterno J; Yasuno K; Günel M
Nat Commun; 2023 Oct; 14(1):6279. PubMed ID: 37805627
[TBL] [Abstract][Full Text] [Related]
9. Genetic landscape of meningioma.
Yuzawa S; Nishihara H; Tanaka S
Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
[TBL] [Abstract][Full Text] [Related]
10. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors.
Lee SJ; Do IG; Lee J; Kim KM; Jang J; Sohn I; Kang WK
Target Oncol; 2013 Dec; 8(4):271-80. PubMed ID: 23371028
[TBL] [Abstract][Full Text] [Related]
12. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma.
Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ
Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
[TBL] [Abstract][Full Text] [Related]
14. The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.
Fountain DM; Smith MJ; O'Leary C; Pathmanaban ON; Roncaroli F; Bobola N; King AT; Evans DG
Oncogene; 2021 Feb; 40(5):875-884. PubMed ID: 33262459
[TBL] [Abstract][Full Text] [Related]
15. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.
Götschel F; Berg D; Gruber W; Bender C; Eberl M; Friedel M; Sonntag J; Rüngeler E; Hache H; Wierling C; Nietfeld W; Lehrach H; Frischauf A; Schwartz-Albiez R; Aberger F; Korf U
PLoS One; 2013; 8(6):e65403. PubMed ID: 23762360
[TBL] [Abstract][Full Text] [Related]
16. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
[TBL] [Abstract][Full Text] [Related]
17. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
19. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and molecular characteristics of pediatric meningiomas.
Battu S; Kumar A; Pathak P; Purkait S; Dhawan L; Sharma MC; Suri A; Singh M; Sarkar C; Suri V
Neuropathology; 2018 Feb; 38(1):22-33. PubMed ID: 28901666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]